Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Willemieke P M DijksterhuisMaarten J PruijtStephanie O van der WoudeRemy KlaassenSophie A KurkMartijn G H van OijenHanneke W M van LaarhovenPublished in: Journal of cachexia, sarcopenia and muscle (2019)
Sarcopenia was not associated with survival or treatment-related toxicity in advanced esophagogastric cancer patients treated with CapOx. Pre-treatment sarcopenic obesity was independently associated with the occurrence of grade 2-4 neurotoxicity and skeletal muscle density with grade 3-4 toxicity.
Keyphrases